Noak Bridge Pharmacy Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 04649635

Noak Bridge Pharmacy Limited

Unaudited financial statements

31 March 2025

Noak Bridge Pharmacy Limited

Statement of financial position

31 March 2025

	2025		2024
Note	£	£	£	£

Fixed assets

Tangible assets	6		200,176		199,332

Current assets

Stocks		27,166	29,423
Debtors	7	105,812	86,606
Cash at bank and in hand		8,283	14,307
		---------	---------
		141,261	130,336

Creditors: Amounts falling due within one year	8	( 192,912)		( 179,797)
		---------		---------
Net current liabilities			( 51,651)		( 49,461)
			---------		---------
Total assets less current liabilities			148,525		149,871

Creditors: Amounts falling due after more than one year	9		( 13,624)		( 38,063)

Provisions

Taxation including deferred tax	( 1,294)	( 1,285)
	---------	---------
Net assets	133,607	110,523
	---------	---------

Capital and reserves

Called up share capital	4	4
Profit and loss account	133,603	110,519
	---------	---------
Shareholders funds	133,607	110,523
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Noak Bridge Pharmacy Limited

Statement of financial position (continued)

31 March 2025

These financial statements were approved by the board of directors and authorised for issue on 31 October 2025 , and are signed on behalf of the board by:

B M Gandecha	Mrs S Gandecha
Director	Director

Company registration number: 04649635

Noak Bridge Pharmacy Limited

Notes to the financial statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Sixty Six, North Quay, Great Yarmouth, Norfolk, NR30 1HE. The trading address is 147 Coppice Lane, Basildon, SS15 4JS.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

Provision is made, under the liability method, to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes. Tax deferred or accelerated is accounted for in respect of all material timing differences.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold property	-	10% straight line
Fixtures and fittings	-	20% straight line
Computer equipment	-	33% straight line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

4. Employee numbers

The average number of employees during the year was 10 (2024: 9 ).

5. Intangible assets

	Goodwill
	£
Cost
At 1 April 2024 and 31 March 2025	167,771
	---------
Amortisation
At 1 April 2024 and 31 March 2025	167,771
	---------
Carrying amount
At 31 March 2025	–
	---------
At 31 March 2024	–
	---------

6. Tangible assets

	Freehold property	Short leasehold property	Fixtures and fittings	Equipment	Total
	£	£	£	£	£
Cost
At 1 April 2024	195,000	84,508	8,704	16,147	304,359
Additions	–	–	4,055	333	4,388
	---------	-------	-------	-------	---------
At 31 March 2025	195,000	84,508	12,759	16,480	308,747
	---------	-------	-------	-------	---------
Depreciation
At 1 April 2024	–	82,309	8,341	14,377	105,027
Charge for the year	–	2,197	263	1,084	3,544
	---------	-------	-------	-------	---------
At 31 March 2025	–	84,506	8,604	15,461	108,571
	---------	-------	-------	-------	---------
Carrying amount
At 31 March 2025	195,000	2	4,155	1,019	200,176
	---------	-------	-------	-------	---------
At 31 March 2024	195,000	2,199	363	1,770	199,332
	---------	-------	-------	-------	---------

7. Debtors

	2025	2024
	£	£
Trade debtors	72,073	76,630
Other debtors	33,739	9,976
	---------	-------
	105,812	86,606
	---------	-------

8. Creditors: Amounts falling due within one year

	2025	2024
	£	£
Bank loans and overdrafts	41,313	31,979
Trade creditors	123,188	107,890
Social security and other taxes	9,375	7,236
Other creditors	19,036	32,692
	---------	---------
	192,912	179,797
	---------	---------

Bank loans and overdrafts are secured by the directors personally.

9. Creditors: Amounts falling due after more than one year

	2025	2024
	£	£
Bank loans and overdrafts	13,624	38,063
	-------	-------

Bank loans and overdrafts are secured by the directors personally.